Celldex Therapeutics Inc CLDX:NASDAQ

RT Quote | Last NYSE, VOL From CTA | USD
Last | 11:09 AM EDT
28.47quote price arrow up+0.36 (+1.28%)
Volume
61,143
52 week range
19.85 - 57.20
Loading...
  • Open28.67
  • Day High29.00
  • Day Low28.14
  • Prev Close28.11
  • 52 Week High57.20
  • 52 Week High Date10/04/21
  • 52 Week Low19.85
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap1.332B
  • Shares Out46.77M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta2.37
  • YTD % Change-26.22

KEY STATS

  • Open28.67
  • Day High29.00
  • Day Low28.14
  • Prev Close28.11
  • 52 Week High57.20
  • 52 Week High Date10/04/21
  • 52 Week Low19.85
  • 52 Week Low Date06/13/22
  • Market Cap1.332B
  • Shares Out46.77M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta2.37
  • YTD % Change-26.22

RATIOS/PROFITABILITY

  • EPS (TTM)-2.14
  • P/E (TTM)-13.28
  • Fwd P/E (NTM)-12.22
  • EBITDA (TTM)-79.236M
  • ROE (TTM)-36.41%
  • Revenue (TTM)820,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-12,093.93%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celldex Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. It operates in development...
Karen Shoos
Non-Executive Independent Chairman of the Board
Anthony Marucci
President, Chief Executive Officer, Director
Sam Martin CPA
Chief Financial Office, Senior Vice President, Secretary
Tibor Keler Ph.D.
Executive Vice President, Chief Scientific Officer
Address
53 Frontage Rd Ste 220
Hampton, NJ
08827-4034
United States

Top Peers

SYMBOLLASTCHG%CHG
AKRO
Akero Therapeutics Inc
33.64-0.41-1.20%
ZNTL
Zentalis Pharmaceuticals Inc
22.87+1.21+5.59%
PCVX
Vaxcyte Inc
24.50+0.50+2.08%
SWTX
SpringWorks Therapeutics Inc
28.28-0.25-0.88%
RYTM
Rhythm Pharmaceuticals Inc
25.17+0.67+2.73%